Echocardiography-based Motion Integration and Management for Substrate Characterization and STAR Therapy in Ventricular Tachycardias (MATRIX-VT)

University of Luebeck

Status: Enrolling

Conditions: Ventricular Arrythmia

Study type: Observational

Funder types: Other

Identifiers

NCT05964660

MATRIX-VT

Details and patient eligibility

About

Prospective, observational, single center, pilot study to analyze the feasibility of motion and structural data integration in patients with ventricular arrhythmia by means of artificial intelligence for improved arrhythmogenic substrate characterization and motion management during stereotactic arrhythmia radioablation.

Full description

This is a prospective, observational, single center, pilot study. Data from preprocedural contrast-enhanced cardiac computed tomography and optically-tracked 3D transthoracic echocardiography of patients receiving catheter ablation for ventricular arrhythmia will be analyzed by means of artificial intelligence in order to better characterize the ventricular arrhythmogenic substrate and to improve the definition methods of the planning target volume during the stereotactic arrhythmia radioablation therapy by integrating the motion data into volume demarcation.

Enrollment: 20 estimated patients

Sex: All

Ages: 18 to 100 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years
• Indication for catheter ablation of ventricular arrhythmias (ventricular fibrillation, ventricular tachycardia, premature ventricular contractions)
• Indication for preprocedural contrast-enhanced cardiac computed tomography for cardiac structure characterization

Exclusion criteria

• Platelet count < 100,000 cells/mm3
• BMI > 45 kg/m2 or < 18 kg/m2

Trial design

20 participants in 1 patient group

VT Patients

Description:

Patients with indication for catheter ablation of ventricular arrhythmia and preprocedural contrast-enhanced cardiac computed tomography for cardiac structure characterization.